Curaleaf Holdings, Inc. <CURA.TO>: Alliance Global Partners adjusts target price to C$21 from C$6.5 to reflect 1-for-3 reverse stock split
Related News
Zoetis cuts annual forecasts as pet healthcare demand slows
ZTS•
Fox posts fiscal 2026 Q4, full-year earnings release report link
FOXA•
Mira Pharma reports positive 7-day dog toxicokinetic study results for obesity drug candidate SKNY-1
MIRA•
Chegg Q2 FY26 net loss narrows to $3 million; revenue drops 51% to $51.8 million
CHGG•
Pacira publishes positive two-year Phase 1 data for PCRX-201 gene therapy in knee osteoarthritis
PCRX•